NA
CDMO

NewEdge Advisors’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

NewEdge Advisors’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-163
Closed -$2.25K – 4235
2022
Q4 		$2.25K Buy
+163
New +$2.5K ﹤0.01% 2810

Other funds holding CDMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

NewEdge Advisors's CDMO Position: Q1 2023 in Review

NewEdge Advisors sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2023, closing a stake of 163 shares — an estimated $2.25K sold.

NewEdge Advisors first reported a position in CDMO in Q4 2022 and held it in 1 quarter. The position peaked at $2.25K in Q4 2022. 168 funds tracked by Wall St. Rank hold CDMO as of Q1 2023.

  • NewEdge Advisors reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • NewEdge Advisors sold 163 Avid Bioservices, Inc. Common Stock shares in Q1 2023, an estimated $2.25K.
  • NewEdge Advisors first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
  • NewEdge Advisors's Avid Bioservices, Inc. Common Stock position peaked at $2.25K in Q4 2022.
  • 168 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2023.

Based on NewEdge Advisors's 13F filing for Q1 2023, filed 12 May 2023.